CD274 and neoplasm: For chemotherapy treated patients, 3 (21.4%) had PD-L1 negative, 9 (64.2%) had tumor with low PD-L1 expression (TPS 1-49%), and 2 (14.4%) had tumor with high PD-L1 (TPS ≥ 50%).